:

Ansu Li1, Qi Li2, Chaoshan Wang2

  • 1Department of Clinical Laboratory, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing University, Nanjing, China.

BMC cancer
|June 24, 2024
PubMed
概括

这项研究确定RBM47是结肠癌 (CC) 中的一个关键预后基因. 它的表达影响患者的生存,并与瘤微环境中的免疫标志物相关,有助于预后评估.